AstraZeneca to set up $500M headquarters, R&D site in the U.K.

06/19/2013 | Reuters · PharmaTimes (U.K.)

AstraZeneca will establish a new global headquarters and research center at the Cambridge Biomedical Campus in England. The move is in line with the drugmaker's plan to build strategic global R&D centers in the U.S., U.K. and Sweden to boost pipeline productivity and establish the firm as an innovation leader. AstraZeneca will invest about $500 million in the site, which will employ roughly 2,000 highly skilled workers by 2016.

View Full Article in:

Reuters · PharmaTimes (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL